A CMV vaccine: TREATing despite the TRICKs
نویسندگان
چکیده
منابع مشابه
Are there more tricks in the bag for treating thrombocytopenia?
Thrombocytopenia, an abnormally low number of circulating platelets, results from inadequate platelet production, splenic platelet sequestration, or accelerated platelet clearance. Platelet transfusions are now the cornerstone for treating thrombocytopenia. With an ever-expanding demand for platelets, and with many patients having an inadequate response to platelet transfusions, new strategies ...
متن کاملPathogenic Bacteria as Vaccine Vectors: Teaching Old Bugs New Tricks
As our scientific knowledge of bacteria grows, so does our ability to manipulate these bacteria to protect rather than infect mammalian hosts from a diverse group of diseases. The old axiom that the best way to protect from a disease is to get infected in the first place is not feasible in the face of the diverse group of pathogens that infect humans. Therefore, reprogramming bacteria to protec...
متن کاملThe March towards a Vaccine for Congenital CMV: Rationale and Models
CMV is a ubiquitous human herpesvirus that causes a lifelong, persistent infection in its host. Whereas primary CMV infections in otherwise healthy individuals are typically asymptomatic and go unnoticed, complications can develop in immunosuppressed individuals following acute CMV infection or CMV reactivation, presenting as retinitis, hepatitis, pneumonitis, gastroenteritis, or other end-orga...
متن کاملOld dogs: new tricks, old tricks, or no tricks.
tively referred to as “old dogs.” In some instances, the designation may be a term of endearment: in others, a term of derision. Virtually every chairperson must face the dilemma of dealing with these senior staff members. His or her decision will be based primarily on how productive the senior radiologist is. I have had the unique opportunity to practice radiology over the past 27 years in bot...
متن کامل454Cytomegalovirus (CMV) Disease after Lung Transplantation (LT) is associated with increased mortality despite Extended Antiviral Prophylaxis
Background. The duration of anti-CMV after LT varies widely among transplant centers. Because CMV is associated with poor outcome, some centers have extended prophylaxis to reduce the rates of CMV disease. We aimed to assess the epidemiology and outcome of CMV infection in high-risk LT recipients receiving extended (and for some, lifelong) prophylaxis. Methods. This is a retrospective review of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Vaccines
سال: 2013
ISSN: 1476-0584,1744-8395
DOI: 10.1586/14760584.2013.844653